The story was buried about as deep in the New York Times as a story can get. Bristol-Myers Co., reported Times Columnist Peter Bart on page 66 one morning last week, had switched its $11 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback